Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma

Isocorydine (ICD), an anticancer agent under current evaluation, decreased the percentage of side population (SP) cells significantly in hepatocellular carcinoma (HCC) cell lines. ICD treatment sensitized cancer cells to doxorubicin (DXR), a conventional clinical chemotherapeutic drug for HCC. We fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lu, Ping, Sun, Hefen, Zhang, Lixing, Hou, Helei, Zhang, Lin, Zhao, Fangyu, Ge, Chao, Yao, Ming, Wang, Tingpu, Li, Jinjun
Formato: Artigo
Idioma:Inglês
Publicado: ScholarOne 2012
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474433/
https://ncbi.nlm.nih.gov/pubmed/22714713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00055
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares